Universe Pharmaceuticals INC

UPC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001809616

SEC filings (opens in a new tab)

No open-market purchases or sales by Universe Pharmaceuticals INC insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $228.4K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Universe Pharmaceuticals INC changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of UPC: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	4	3	−1
Shares	289.6K	44.2K	−245.4K (−84.7%)
Value	$181.0K	$24.0K	−$157.0K (−86.7%)

New holders (1)

Institutions that held Universe Pharmaceuticals INC at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to UPC in Q3 2022
Institution	Shares	Value	% of portfolio
UBS Group AG	9,014	$5.00K	0.00%

Sold out (2)

Institutions that held Universe Pharmaceuticals INC at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of UPC in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Pura Vida Investments, LLC	239,482	$150.0K
Two Sigma Securities, LLC	16,349	$10.0K